Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-058373
Filing Date
2010-03-16
Accepted
2010-03-16 16:09:43
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1358993
2 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 1566
3 CONSENT OF DELOITTE & TOUCHE LLP dex231.htm EX-23.1 1895
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9688
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9697
6 SECTION 906 CEO AND CFO CERTIFICATIONS dex32.htm EX-32 4234
7 GRAPHIC g93949g61a36.jpg GRAPHIC 53129
  Complete submission text file 0001193125-10-058373.txt   1460818
Mailing Address 160 SECOND STREET CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE MA 02142 617-492-5554
Molecular Insight Pharmaceuticals, Inc. (Filer) CIK: 0001340752 (see all company filings)

EIN.: 043412465 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33284 | Film No.: 10685625
SIC: 2834 Pharmaceutical Preparations